Pricing Log in Create free account

20/20 Biolabs Inc. (AIDX) vs Vivos Therapeutics, Inc. (VVOS)

20/20 Biolabs Inc. and Vivos Therapeutics, Inc. are both Medical Devices companies. Vivos Therapeutics, Inc. is the larger, with a market value of $3.5M against $2.5M — 1.4× the size. Vivos Therapeutics, Inc. has the higher net margin (−121.8% vs −298.2%) and the lower return on invested capital (−592.7% vs 0.00%). Across the 15 metrics below, Vivos Therapeutics, Inc. leads on 9 and 20/20 Biolabs Inc. on 6.

Valuation

Metric AIDX VVOS Medical Devices median
P/E n/m n/m 24.94
P/S 0.99 0.08 2.66
P/B 1.33 n/m 2.36
Price to free cash flow n/m n/m 28.12
EV/EBITDA 0.39 n/m 11.42
EV/Sales (0.67) 0.38 2.76
Earnings yield (436.45%) (2,111.11%) (12.66%)
Free cash flow yield (201.49%) (1,194.75%) (7.18%)

Profitability

Metric AIDX VVOS Medical Devices median
Gross margin 32.06% 61.89% 57.76%
Operating margin (198.15%) (107.89%) (14.84%)
Net margin (298.16%) (121.79%) (14.45%)
Free cash flow margin (200.12%) (90.97%) (5.70%)
Return on equity 0.00% 10,022.05% (10.56%)
Return on assets (211.61%) (101.46%) (17.26%)
Return on invested capital 0.00% (592.70%) (5.22%)

Growth

Metric AIDX VVOS Medical Devices median
Revenue growth (TTM) — 45.21% 10.41%
EPS growth (last fiscal year) 34.28% 6.76% 28.17%
Revenue growth, 5-year CAGR — 5.95% 15.74%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AIDX VVOS Medical Devices median
Debt to equity 0.00 (2.04) 0.04
Current ratio 1.99 0.21 2.67
Net debt to EBITDA 0.11 (0.37) 0.54

Dividend

Metric AIDX VVOS Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.38

Size

Metric AIDX VVOS Medical Devices median
Market cap 2.50m 3.45m 221.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack